AJP - Regu Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 282: R166-R172, 2002;
0363-6119/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (48)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iversen, P. O.
Right arrow Articles by Christensen, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iversen, P. O.
Right arrow Articles by Christensen, G.
Vol. 282, Issue 1, R166-R172, January 2002

Decreased hematopoiesis in bone marrow of mice with congestive heart failure

Per Ole Iversen1, Per Reidar Woldbaek2,3, Theis Tønnessen2,3, and Geir Christensen2

1 Institute for Nutrition Research, University of Oslo; 2 Institute for Experimental Medical Research, and 3 Department of Cardiothoracic Surgery, Ullevål University Hospital, 0316 Oslo, Norway

Patients with heart failure are predisposed to infections and anemia, possibly due to reduced hematopoiesis. The proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha ) is increased in heart failure, and it inhibits normal hematopoiesis, partly due to apoptosis through the effector molecule Fas. We examined bone marrow progenitor cells of mice with heart failure induced by acute myocardial infarction. The fraction of progenitor cells in mice with heart failure was only ~40% of control. Measured with in vitro clonal assays, the proliferative capacity of the progenitor cells in mice with heart failure was reduced to ~50% of control. Flow cytometry with specific markers revealed a threefold increase in apoptosis among progenitor cells from mice with heart failure. In these mice, TNF-alpha /Fas expression was increased in bone marrow natural killer (NK) and T cells, and these lymphocytes showed increased cytolytic activity in vitro against progenitor cells. We conclude that the TNF-alpha /Fas pathway in lymphocytes is activated in the bone marrow during heart failure, which may play a pathogenic role in the observed decrease in hematopoiesis.

blood cells; bone marrow cells; immunity; myocardial infarction


This article has been cited by other articles:


Home page
HeartHome page
P. van der Meer and D. J van Veldhuisen
Anaemia and renal dysfunction in chronic heart failure
Heart, November 1, 2009; 95(21): 1808 - 1812.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. S. Anand
Anemia and Chronic Heart Failure: Implications and Treatment Options
J. Am. Coll. Cardiol., August 12, 2008; 52(7): 501 - 511.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. N. Nanas, C. Matsouka, D. Karageorgopoulos, A. Leonti, E. Tsolakis, S. G. Drakos, E. P. Tsagalou, G. D. Maroulidis, G. P. Alexopoulos, J. E. Kanakakis, et al.
Etiology of Anemia in Patients With Advanced Heart Failure
J. Am. Coll. Cardiol., December 19, 2006; 48(12): 2485 - 2489.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
N. Valeur, O. W. Nielsen, J. J.V. McMurray, C. Torp-Pedersen, L. Kober, and TRACE Study Group
Anaemia is an independent predictor of mortality in patients with left ventricular systolic dysfunction following acute myocardial infarction
Eur J Heart Fail, October 1, 2006; 8(6): 577 - 584.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. S. Go, J. Yang, L. M. Ackerson, K. Lepper, S. Robbins, B. M. Massie, and M. G. Shlipak
Hemoglobin Level, Chronic Kidney Disease, and the Risks of Death and Hospitalization in Adults With Chronic Heart Failure: The Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study
Circulation, June 13, 2006; 113(23): 2713 - 2723.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y.-D. Tang and S. D. Katz
Anemia in Chronic Heart Failure: Prevalence, Etiology, Clinical Correlates, and Treatment Options
Circulation, May 23, 2006; 113(20): 2454 - 2461.
[Full Text] [PDF]


Home page
Eur Heart JHome page
D. O. Okonko, D. J. Van Veldhuisen, P. A. Poole-Wilson, and S. D. Anker
Anaemia of chronic disease in chronic heart failure: the emerging evidence
Eur. Heart J., November 1, 2005; 26(21): 2213 - 2214.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. O. Iversen and H. Wiig
Tumor Necrosis Factor {alpha} and Adiponectin in Bone Marrow Interstitial Fluid from Patients with Acute Myeloid Leukemia Inhibit Normal Hematopoiesis
Clin. Cancer Res., October 1, 2005; 11(19): 6793 - 6799.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
K. Caiola and J. W. Cheng
Use of Erythropoietin in Heart Failure Management
Ann. Pharmacother., December 1, 2004; 38(12): 2145 - 2149.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A J S Coats
Anaemia and heart failure
Heart, September 1, 2004; 90(9): 977 - 979.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Wiig, E. Berggreen, B. A. S. Borge, and P. O. Iversen
Demonstration of altered signaling responses in bone marrow extracellular fluid during increased hematopoiesis in rats using a centrifugation method
Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H2028 - H2034.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
A. V. Finsen, P. R. Woldbaek, J. Li, J. Wu, T. Lyberg, T. Tonnessen, and G. Christensen
Increased syndecan expression following myocardial infarction indicates a role in cardiac remodeling
Physiol Genomics, February 13, 2004; 16(3): 301 - 308.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. van der Meer, A. A. Voors, E. Lipsic, W. H. van Gilst, and D. J. van Veldhuisen
Erythropoietin in cardiovascular diseases
Eur. Heart J., February 2, 2004; 25(4): 285 - 291.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Schroecksnadel, B. Wirleitner, D. Fuchs, W. Steinborn, P. Ponikowski, S. Anker, P. van der Meer, W. H. van Gilst, D. J. van Veldhuisen, J. Ezekowitz, et al.
Anemia and Congestive Heart Failure * Response
Circulation, August 12, 2003; 108 (6): e41 - e42.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
D. Silverberg
Outcomes of anaemia management in renal insufficiency and cardiac disease
Nephrol. Dial. Transplant., June 1, 2003; 18(suppl_2): ii7 - ii12.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. A. Ezekowitz, F. A. McAlister, and P. W. Armstrong
Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes: Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure
Circulation, January 21, 2003; 107(2): 223 - 225.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
D. S. Silverberg, D. Wexler, M. Blum, J. Z. Tchebiner, D. Sheps, G. Keren, D. Schwartz, R. Baruch, T. Yachnin, M. Shaked, et al.
The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron
Nephrol. Dial. Transplant., January 1, 2003; 18(1): 141 - 146.
[Abstract] [Full Text] [PDF]


Home page
Sci Aging Knowl EnvironHome page
J. M. Edelberg
Auto Repair on the Aging Stem Cell Superhighway
Sci. Aging Knowl. Environ., September 4, 2002; 2002(35): pe13 - 13.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online